Literature DB >> 1517795

Neuropsychologic and neurologic side effects of mitotane and reversibility of symptoms.

J B Lanser, A P van Seters, A J Moolenaar, H R Haak, E L Bollen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1517795     DOI： 10.1200/JCO.1992.10.9.1504

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Long QT syndrome under mitotane therapy.

Authors:  R U Pliquett; U Eichfeld; M Stumvoll; C A Koch
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

Review 2.  Health-Related Quality of Life in Adrenocortical Carcinoma.

Authors:  Rebecca V Steenaard; Laura A Michon; Harm R Haak
Journal:  Cancers (Basel)       Date:  2019-10-08       Impact factor: 6.639

Review 3.  EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity.

Authors:  Rebecca V Steenaard; Marieke Rutjens; Madeleine H T Ettaieb; Max M van Noesel; Harm R Haak
Journal:  Discov Oncol       Date:  2022-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.